Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. - Wikidata - wikimedia - TriplyDB

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.

http://www.wikidata.org/entity/Q35735316

about

15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells A novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosis Lipid metabolic reprogramming in cancer cells Obesity and cancer: mechanistic insights from transdisciplinary studies The role of the EP receptors for prostaglandin E2 in skin and skin cancer COX-2 and PGE2-dependent immunomodulation in breast cancer Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers Current evidence linking polyunsaturated Fatty acids with cancer risk and progression Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis Cyclooxygenase in the treatment of glioma: its complex role in signal transduction Potential use of COX-2-aromatase inhibitor combinations in breast cancer Prostaglandins and cancer Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer Pharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis Cytosolic phospholipase A2 activation correlates with HER2 overexpression and mediates estrogen-dependent breast cancer cell growth.Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells.Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer.Breast cancer cell cyclooxygenase-2 expression alters extracellular matrix structure and function and numbers of cancer associated fibroblasts.Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) inhibits cell growth in a mouse mammary gland cancer cell line.PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis.COX-2 in liver, from regeneration to hepatocarcinogenesis: what we have learned from animal models?COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling Thalidomide-a notorious sedative to a wonder anticancer drug.Eicosanoids and cancer Suppression of integrin alpha3beta1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells.Effect of 15-lipoxygenase metabolites on angiogenesis: 15(S)-HPETE is angiostatic and 15(S)-HETE is angiogenic.Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities.The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target.Regulation of COX2 expression in mouse mammary tumor cells controls bone metastasis and PGE2-induction of regulatory T cell migration.Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?The cyclooxygenase inhibitor sulindac sulfide inhibits EP4 expression and suppresses the growth of glioblastoma cells.Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesis 15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis.Cystic duct dilatations and proliferative epithelial lesions in mouse mammary glands upon keratin 5 promoter-driven overexpression of cyclooxygenase-2.Lipid Signaling in Tumorigenesis.Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.

P2860

Q24318523-9A5CEFD8-93E8-4185-9266-22D5EFF9EF96 Q24653404-076F1309-8D6A-462B-B6A9-5A9555545474 Q24810540-234DE00E-D66E-44FE-904E-88DCA6460B83 Q26774351-A3A81C9D-C424-4B7E-9537-5A84E0778BE3 Q26774859-AD1A71B7-FF12-47C3-9E4D-C3257D20CC0A Q26786829-5D35D82A-C72B-4280-99DB-32CEF9AF0D38 Q26999707-E050FAB6-B762-48DD-9EDA-5FE319A7BAA0 Q27003937-2D8BA653-0441-44E9-A98D-193DADDE1C86 Q27016106-9A8BFBF6-2E90-415A-9136-3723E9065024 Q27022573-03791834-B02A-4F70-BCEB-4062F32E073E Q28075646-EA32C769-652A-4DF0-8172-2D37E64B753C Q28168685-8F19143B-2121-404E-B810-688410FE6C58 Q28187414-90B1758A-BDE1-4FCB-B90E-6E6C39D8E0C3 Q28188827-1BDA2937-5FC9-426A-ABB4-7381628F991A Q28218639-181A02ED-141F-40DF-A058-AB50425E47C2 Q28481397-D7E2A135-94C1-400B-9E9B-817013549933 Q30352693-1CF368C9-25FB-4978-A29F-4D0836A1E840 Q33260568-E1CE3BE4-CF7F-4745-BF65-3ED1D7AC7FD9 Q33475171-D8D69196-02DF-46B6-BD2D-A1D3BC78F066 Q33566771-F284DF6E-9395-4111-93CA-9A11CB8FF430 Q33625872-3804F0E5-64EF-4FC9-8908-B898E34D6E17 Q33752909-390B4335-99C4-450F-8D0C-E1ECF9FBC0E6 Q33756224-B4B76558-9B17-4684-B110-AE27F2D6B76B Q33877411-24983E82-664C-4E89-8BA8-A9E841C6D285 Q33886682-A5DC11F3-286D-4B87-9EFD-574F89C0D728 Q33956871-E539DFCE-E19B-4787-9134-BF62D733F8DD Q33966203-D70A7634-C584-49D7-800C-553D494475C7 Q34032403-302D7D0B-C6E3-42A2-BE75-C346B717D968 Q34263826-5AA0B58B-38A0-4016-8984-D2CD964479C8 Q34279863-994E4D8F-CDEE-4216-88B0-AB2AEB465C32 Q34342416-02F9BA6E-C9DC-4C1E-BF0F-20C6D57BE0A3 Q34431108-B263EF33-55A3-41D4-B191-9D631204365A Q34452014-B14B85B0-7E95-4BF0-81AF-354984CC1F71 Q34494513-E30D9B79-20F8-4A4D-999F-F85043ABF26A Q34614124-4CBA2387-15D7-4B87-9C68-CCEE56EB079B Q34662175-D65EEF1A-7A23-4173-8490-DF2D3493BABC Q35033202-064B07B5-51F7-4829-BAF1-4C68AB4B7ABA Q35083639-A073747C-360B-4800-9EF1-DF6D6AE4622C Q35136532-2E37655A-2B78-46B3-97EF-F5194EC5962A Q35186471-A221A50F-FD02-4321-A40A-C0DBC1182619

P2860

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.

http://www.wikidata.org/entity/Q35735316

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Role of prostaglandin E2-depen ...... ced breast cancer progression.

@ast

Role of prostaglandin E2-depen ...... ced breast cancer progression.

@en

type

label

Role of prostaglandin E2-depen ...... ced breast cancer progression.

@ast

Role of prostaglandin E2-depen ...... ced breast cancer progression.

@en

prefLabel

Role of prostaglandin E2-depen ...... ced breast cancer progression.

@ast

Role of prostaglandin E2-depen ...... ced breast cancer progression.

@en

P1433

Q35735316-B46A057C-DB6D-4335-BC19-475A91871BF2

P1476

Q35735316-5A565EBD-3C97-474D-9840-9A14B0A48844

P2093

Q35735316-48641782-7FDC-4761-8958-CFA4F162F314

Q35735316-8FB1D3F2-8D4A-4852-8E89-D938B25B9585

Q35735316-9C0ADFDB-BDB2-4F92-B979-5F0F1FFC37B0

Q35735316-B6508150-5E2F-44F2-88DA-880767E74D07

Q35735316-CF1FB0C1-7D1B-4456-96FA-EA2F30ACD4EA

Q35735316-E20C9CA2-85CE-450F-84B0-EE23B7490015

Q35735316-F3B345D3-2AF3-4367-9340-B80F3D456B47

Q35735316-FBA3C0C2-48D4-48C9-80ED-939B4369026D

P2860

Q35735316-0EE95EE5-8624-44FD-86A6-F86847129845

Q35735316-134B1B80-7E26-4628-A911-7F03AD6FB551

Q35735316-1B997BD2-B70C-47C8-A4F2-FCC0B5B61730

Q35735316-31C84CA1-0A56-41DC-90B6-812AAA50FFBB

Q35735316-32A0E799-8372-4E8B-882E-9BC468A065F2

Q35735316-39D16D82-5367-468D-A022-B8ED80A0CF26

Q35735316-3B1E565D-F8EE-4359-B73F-475EB521E7BD

Q35735316-3EF4004A-CA61-4B34-8167-C943A950651E

Q35735316-4251CDCD-9F6E-48CE-803C-7C116C14B110

Q35735316-44971BF5-2728-4C31-8203-9C3A72E3D20F

P304

Q35735316-7A8111D6-DD17-41DA-A259-3160BA157DA2

P31

Q35735316-9FD2AF22-F49A-4983-BD29-A16F9AEC4925

P356

Q35735316-A0266D04-6F2F-497F-B3B4-9B0CA1874264

P407

Q35735316-BD6C0049-A5D8-4AB4-B007-F851A5802253

P433

Q35735316-F6D401D3-D582-4EE6-A00B-8344FAB76AE8

P478

Q35735316-E944DB89-CC5C-4245-9FB9-1B1F17C36D71

P577

Q35735316-173AD2A0-0BC5-45E3-A124-C4949DAF9D97

P5875

Q35735316-C134194F-730F-4699-BCCD-3BF8D59D06E2

P698

Q35735316-932C53BD-9CE8-4F8D-BD63-8F2AAA97E5BD

P932

Q35735316-25DF5E6E-0356-476C-A282-87D0A5AB9170

P356

PNAS.2535911100

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Role of prostaglandin E2-depen ...... ced breast cancer progression.

@en

P2093

Catherine H Liu

http://www.w3.org/2001/XMLSchema#string

David K Han

http://www.w3.org/2001/XMLSchema#string

Kasem Nithipatikom

http://www.w3.org/2001/XMLSchema#string

Ovidiu C Trifan

http://www.w3.org/2001/XMLSchema#string

Rebecca Conway

http://www.w3.org/2001/XMLSchema#string

Sung-Hee Chang

http://www.w3.org/2001/XMLSchema#string

Timothy F Lane

http://www.w3.org/2001/XMLSchema#string

Timothy Hla

http://www.w3.org/2001/XMLSchema#string

P2860

Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation

Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps

Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Vascular-specific growth factors and blood vessel formation

Cyclooxygenases: structural, cellular, and molecular biology

Cyclooxygenase-1 and -2 isoenzymes.

The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.

Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.

P304

591-596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.2535911100

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8949063

http://www.w3.org/2001/XMLSchema#string

P698

14688410

http://www.w3.org/2001/XMLSchema#string

P932

327192

http://www.w3.org/2001/XMLSchema#string